Literature DB >> 2230253

Cefepime for treatment of experimental chronic osteomyelitis due to Staphylococcus aureus.

C W Norden, E A Gill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2230253     DOI： 10.1093/infdis/162.5.1218

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

Review 1.  Cefepime clinical pharmacokinetics.

Authors:  M P Okamoto; R K Nakahiro; A Chin; A Bedikian
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

2.  Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureus.

Authors:  Li-Yan Yin; Jason H Calhoun; Jacob K Thomas; Stuart Shapiro; Anne Schmitt-Hoffmann
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

3.  A different perspective for radiological evaluation of experimental osteomyelitis.

Authors:  Cem Nuri Aktekin; Akif Muhtar Ozturk; Abdullah Yalcin Tabak; Murat Altay; Feza Korkusuz
Journal:  Skeletal Radiol       Date:  2007-07-12       Impact factor: 2.199

Review 4.  Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  L B Barradell; H M Bryson
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.